이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Dr. Sulaiman Al Habib Medical Services Group 과거 수익 실적
과거 기준 확인 3/6
Dr. Sulaiman Al Habib Medical Services Group은 연평균 20.5%의 비율로 수입이 증가해 온 반면, Healthcare 산업은 수입이 증가했으며, 연간 18.7%였습니다. 매출은 연평균 15.7%의 비율로 증가했습니다. Dr. Sulaiman Al Habib Medical Services Group의 자기자본이익률은 31.4%이고 순이익률은 21.7%입니다.
주요 정보
20.5%
수익 성장률
20.5%
EPS 성장률
Healthcare 산업 성장 | 12.3% |
매출 성장률 | 15.7% |
자기자본 수익률 | 31.4% |
순이익 | 21.7% |
최근 수익 업데이트 | 30 Jun 2024 |
최근 과거 실적 업데이트
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27수익 및 비용 분석
Dr. Sulaiman Al Habib Medical Services Group 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
30 Jun 24 | 10,024 | 2,176 | 1,257 | 0 |
31 Mar 24 | 9,723 | 2,108 | 1,206 | 0 |
31 Dec 23 | 9,508 | 2,046 | 1,158 | 0 |
30 Sep 23 | 9,276 | 1,962 | 1,134 | 0 |
30 Jun 23 | 8,885 | 1,838 | 1,089 | 0 |
31 Mar 23 | 8,627 | 1,750 | 1,069 | 0 |
31 Dec 22 | 8,311 | 1,651 | 1,032 | 0 |
30 Sep 22 | 8,025 | 1,593 | 971 | 0 |
30 Jun 22 | 7,809 | 1,521 | 932 | 0 |
31 Mar 22 | 7,547 | 1,448 | 887 | 0 |
31 Dec 21 | 7,250 | 1,377 | 850 | 0 |
30 Sep 21 | 6,974 | 1,311 | 822 | 0 |
30 Jun 21 | 6,761 | 1,261 | 851 | 0 |
31 Mar 21 | 6,213 | 1,128 | 796 | 0 |
31 Dec 20 | 5,862 | 1,055 | 738 | 0 |
30 Sep 20 | 5,575 | 1,008 | 696 | 0 |
30 Jun 20 | 5,178 | 907 | 618 | 0 |
31 Mar 20 | 5,132 | 883 | 632 | 0 |
31 Dec 19 | 5,016 | 870 | 647 | 0 |
30 Sep 19 | 4,816 | 825 | 619 | 0 |
30 Jun 19 | 4,735 | 835 | 601 | 0 |
31 Mar 19 | 4,646 | 819 | 569 | 0 |
31 Dec 18 | 4,588 | 801 | 551 | 0 |
31 Dec 17 | 4,687 | 658 | 904 | 0 |
31 Dec 16 | 4,868 | 1,010 | 959 | 0 |
31 Dec 15 | 5,123 | 1,329 | 859 | 0 |
양질의 수익: 4013 의 비현금 수입 수준이 높습니다.
이익 마진 증가: 4013 의 현재 순이익 이익률 (21.7%) 작년보다 높습니다 (20.3%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: 4013 의 수익은 지난 5년 동안 매년 20.5% 씩 크게 증가했습니다.
성장 가속화: 지난 1년간 4013 의 수익 증가율( 18.4% )은 5년 평균( 20.5% 보다 낮습니다. 년도).
수익 대 산업: 지난 1년간 4013 수익 성장( 18.4% )은 Healthcare 업계 42.3% 능가하지 못했습니다. 42.3%.
자기자본 수익률
높은 ROE: 4013 의 자본 수익률( 31.4% )은 높음으로 간주됩니다.